Description
A summary of major trends in the IVD industry, from harmonization to Cardiac marker testing.
Published on: June 7, 2018
Table of Contents
- In this issue
- 3 Indidcations Regulators are Building a Pathway for Clinical Sequencing-Based Tests
- Cardiac Markers
- Harmonization of Lab Tests
Clinical Diagnostics in China – Market Sector Analyses and Participant Directory
November 1, 2005- Price: $4,995 – $9,990
Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease
December 1, 2003- Price: $1,496 – $2,992
Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential
October 1, 2004- Price: $995 – $1,990
Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease
April 1, 2004- Price: $1,995 – $3,990
Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- Infographic: Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) July 26, 2021
- $41 Billion U.S. In Vitro Diagnostics (IVD) Market to Grow 5% Through 2025 July 19, 2021
- COVID-19 Testing Increases Demand in $150 Billion Clinical Laboratory Services Market, Future Growth Linked to Global Economies June 28, 2021
- Molecular Diagnostics Market to Reach 28 Billion. We Didn’t Predict That Two Years Ago. June 21, 2021
- Oncologists Urge Faster Biomarker Results for Lung Cancer Patients June 8, 2021
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group